Chronic pain and cognitive impairment frequently coexist in older adults, creating a self-reinforcing loop that accelerates functional decline, increases disability, and reduces quality of life. More than half of patients in pain clinics report cognitive difficulties, and roughly 45 to 50 percent of people living with dementia experience chronic pain. Longitudinal evidence demonstrates that persistent pain is associated with accelerated cognitive decline and elevated dementia risk. In a large nationally representative cohort of more than 10,000 older adults, researchers found that persistent moderate-to-severe pain was linked to 9.2 percent more rapid memory decline and a higher probability of dementia over time. Other cohort studies and meta-analyses have similarly shown that pain, and particularly pain interference with daily activities, can predict subsequent cognitive decline and dementia.
The relationship is bidirectional. Cognitive deficits amplify pain perception, impair adaptive coping, reduce treatment adherence, and worsen disability. Declining executive function and working memory weaken the top-down inhibitory control that normally modulates pain, making catastrophic thoughts, fear-avoidance, and attentional fixation on pain more difficult to interrupt.
Underlying mechanisms
This is not merely correlative. Shared neurobiological pathways help explain the association. Chronic pain is linked to neuroinflammation, microglial activation, and structural and functional changes in the prefrontal cortex, hippocampus, and related networks that support attention, executive control, memory, and emotional regulation. These changes contribute to accelerated brain aging. Persistent nociceptive input can exacerbate neurodegenerative processes, while cognitive impairment further impairs pain modulation, creating a mutually reinforcing cycle. The result is a cycle in which untreated pain accelerates cognitive loss, and cognitive loss amplifies pain.
Clinical implications
Recognizing this bidirectional relationship has practical consequences for everyday care. Cognitive complaints in patients with chronic pain should not be dismissed as incidental or solely age-related. Likewise, pain complaints in patients with mild cognitive impairment or early dementia warrant careful evaluation rather than attribution solely to the neurodegenerative process. Both domains influence treatment adherence, functional recovery, fall risk, medication management, and caregiver burden.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Functional staging tools that rely on informant input, such as the Functional Assessment Staging (FAST) scale, can help characterize the degree of functional decline associated with cognitive impairment. Because insight diminishes as dementia advances, caregiver or knowledgeable informant reports are essential for accurate staging beyond the earliest phases. This information informs realistic goal setting, safety planning, and the intensity of support required. FAST, developed by Dr. Barry Reisberg, is a widely used clinical staging tool that tracks the progressive functional decline in Alzheimer’s disease and related dementias. It focuses on how well a person can perform everyday activities rather than pure cognitive testing (like memory or orientation scores).
Traditional siloed approaches of treating pain with procedures or medications while ignoring cognition or addressing cognition without addressing pain drivers will miss the opportunity to interrupt this cycle. Improving cognitive and behavioral factors can enhance top-down pain control, reduce catastrophizing, improve self-management, and support functional recovery. Simple, sustained cognitive engagement, such as regular journal writing, has been associated with better performance on cognitive screening measures in older adults, both community-dwelling and in care settings. Structured cognitive-behavioral strategies further target the psychological and cognitive barriers that perpetuate pain.
Pharmacological interventions
Pharmacologic choices must balance analgesic benefit against cognitive risk, especially in older adults. Long-term opioid therapy is associated with deficits in attention, memory, and executive function and carries heightened risks of falls, sedation, and delirium. In patients with existing cognitive impairment or dementia, opioids such as buprenorphine can increase psychiatric and neurological adverse events and reduce daytime activity. Guidelines therefore recommend opioids only after other strategies have been tried and after careful risk-benefit assessment.
Non-opioid options are preferred first-line in most cases. Topical and oral NSAIDs can provide benefit for inflammatory and musculoskeletal pain but carry gastrointestinal, renal, and cardiovascular risks that increase with age and comorbidity. Acetaminophen remains a commonly used first-line agent for mild-to-moderate pain, including in patients with dementia, although evidence for long-term efficacy is limited. For neuropathic components, serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine and certain gabapentinoids (gabapentin, pregabalin) have moderate evidence of benefit. However, gabapentinoids require cautious dosing in older adults because of sedation, fall risk, and potential cognitive side effects. Tricyclic antidepressants are generally avoided due to anticholinergic burden. Overall, pharmacologic management should prioritize the lowest effective doses, regular reassessment of cognitive and functional status, and deprescribing when risks outweigh benefits.
Non-pharmacological interventions. Evidence-informed interventions that address both domains
Interventions that strengthen cognitive and behavioral capacities can improve both pain-related outcomes and cognitive performance. Cognitive-behavioral approaches that target catastrophizing, fear-avoidance, and maladaptive coping have demonstrated benefits for pain intensity, interference, and psychological distress. When combined with physical modalities or physiotherapy, these approaches can also enhance executive function in older adults with chronic musculoskeletal pain.
Structured cognitive engagement shows promise as a low-burden adjunct. Regular journal writing, for example, has been associated with better performance on cognitive screening measures among older adults living independently and those in care settings. The act of writing engages attention, memory, language, and organizational skills while providing an outlet for emotional processing of the pain experience. Other forms of lifelong cognitive enrichment like reading, writing, and continued learning all are linked in observational data to lower risk of Alzheimer’s disease and milder cognitive impairment, as well as delayed onset of clinical symptoms.
Computerized cognitive training programs targeting flexibility, attention, and working memory have produced modest gains in executive performance among chronic pain patients in controlled trials, with some signals of secondary benefit for pain severity. Mindfulness-based and self-compassion approaches, particularly when integrated with cognitive-behavioral principles, further support emotional regulation and attentional control that are often compromised by both pain and cognitive decline.
Multimodal strategies that simultaneously address physical function, cognitive skills, and behavioral patterns appear most promising. Exercise combined with cognitive-behavioral therapy has shown improvements in cognitive performance among older adults with multisite chronic pain. These findings underscore the value of interdisciplinary models that treat the brain and the body as interdependent rather than sequential targets.
Moving forward in clinical practice
The evidence supports a shift from viewing cognition and pain as separate problems toward recognizing them as interconnected processes that can be addressed concurrently. Simple steps of systematically inquiring about cognitive concerns in patients with persistent pain, obtaining informant input when indicated, encouraging cognitively engaging activities such as structured writing, and integrating cognitive-behavioral strategies into pain self-management, all can help interrupt the cycle.
For older adults living with chronic pain, protecting and enhancing cognitive function is not a secondary consideration. It is central to restoring adaptive coping, improving adherence, reducing disability, and preserving independence.
Kayvan Haddadan is a physiatrist and pain management physician, and president and medical director of Advanced Pain Diagnostic & Solutions, a multidisciplinary pain management practice in California that he founded in 2012. A physician and surgeon licensed by the Medical Board of California, he is double board-certified in pain medicine and physical medicine and rehabilitation. He is also certified in controlled substance registration through the DEA and serves as a qualified medical examiner through California’s Department of Industrial Relations Division of Workers’ Compensation.
Dr. Haddadan earned his Bachelor of Science degree from the College of Alborz in Tehran, Iran, and his medical degree from Shahid Beheshti University of Medical Sciences. He later received his Educational Commission for Foreign Medical Graduates certification in Philadelphia, completed an internship in medical surgery at Loyola University Medical Center’s Stritch School of Medicine in Illinois, and finished his residency in physical medicine and rehabilitation at the same institution. He completed his fellowship in pain medicine at California Pacific Medical Center’s Pacific Pain Treatment Center and also trained in medical acupuncture for physicians at the University of California, Los Angeles David Geffen School of Medicine.
Dr. Haddadan has contributed to 29 research publications across multiple specialties, including pain management, cardiology, pulmonology, endocrinology, gastroenterology, and infectious disease. His work has examined topics such as hyperlipidemia in high cardiovascular risk patients, hyperuricemia and gout management, type 2 diabetes and hypertension, chronic obstructive pulmonary disease and asthma therapies, influenza treatment, irritable bowel syndrome, and opioid related complications in chronic pain care. His research has also included clinical outcome studies in spinal cord stimulation and award-winning presentations on neuropathic pain management and neuromuscular disorders.
